Moderna and Merck reported in August 2026 that their clinical trial for an experimental melanoma cancer vaccine met endpoints for preventing recurrence and distant metastasis

Health

Biological preparations that stimulate the immune system to recognize and protect against infectious diseases by inducing a targeted immune response.

1 debate·6,997 claims·43 news stories